Are you Dr. Mutter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-7536
Summary
- Dr. George Mutter, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, New Jersey, and New York. He is affiliated with Brigham and Women's Hospital and is a Professor at Harvard Medical School.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1982 - 1988
Harvard Medical SchoolClass of 1982
Certifications & Licensure
NJ State Medical License 1987 - Present
NY State Medical License 1984 - Present
MA State Medical License 1988 - 2025- American Board of Pathology Anatomic Pathology
Clinical Trials
- Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer Start of enrollment: 1998 Nov 01
Publications & Presentations
PubMed
- 23 citationsTemplate for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium.Teri A. Longacre, Russell Broaddus, Linus Chuang, Michael B. Cohen, Elke A. Jarboe
Archives of Pathology & Laboratory Medicine. 2017-03-16 - 315 citationsImmunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the BreastAurel Perren, Liang Ping Weng, Alexander Boag, Ulricke Ziebold, Kosha Thakore
The American Journal of Pathology. 1999-10-01 - 357 citationsA compendium of gene expression in normal human tissues.Li Li Hsiao, Fernando Dangond, Takumi Yoshida, Robert L. Hong, Roderick V. Jensen
Physiological Genomics. 2001-12-21
Grant Support
- Hormonal Modulation Of Latent Endometrial PrecancersNational Cancer Institute2004–2008
- Biomarkers And Chemoprevention Of Endometrial CancerNational Cancer Institute2002–2006
- Cellular Oncogenes In Germ Cell TumorsNational Cancer Institute1989–1993
- C-Mos Expression In Normal Reproduction And DevelopmentEunice Kennedy Shriver National Institute Of Child Health &Human Development1986–1987
